Tom B. Davidson

2.3k total citations
30 papers, 383 citations indexed

About

Tom B. Davidson is a scholar working on Genetics, Neurology and Oncology. According to data from OpenAlex, Tom B. Davidson has authored 30 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 11 papers in Neurology and 10 papers in Oncology. Recurrent topics in Tom B. Davidson's work include Glioma Diagnosis and Treatment (17 papers), Neuroblastoma Research and Treatments (10 papers) and Brain Metastases and Treatment (7 papers). Tom B. Davidson is often cited by papers focused on Glioma Diagnosis and Treatment (17 papers), Neuroblastoma Research and Treatments (10 papers) and Brain Metastases and Treatment (7 papers). Tom B. Davidson collaborates with scholars based in United States, Australia and Canada. Tom B. Davidson's co-authors include Linda M. Liau, Robert M. Prins, Myles Cockburn, William H. Yong, Julia E. Heck, Andrew S. Park, Zuelma A. Contreras, Beate Ritz, Eduard H. Panosyan and Theodore B. Moore and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Tom B. Davidson

26 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom B. Davidson United States 11 133 128 120 87 68 30 383
Arthur Wingerter Germany 10 121 0.9× 200 1.6× 53 0.4× 56 0.6× 49 0.7× 26 419
Gabriel N. Mannis United States 13 120 0.9× 152 1.2× 151 1.3× 51 0.6× 36 0.5× 64 600
Hien K. Duong United States 8 104 0.8× 100 0.8× 107 0.9× 100 1.1× 38 0.6× 30 425
Claudia Pasqualini France 12 180 1.4× 71 0.6× 58 0.5× 41 0.5× 49 0.7× 31 372
J. P. Lamagnere France 10 85 0.6× 137 1.1× 97 0.8× 44 0.5× 44 0.6× 19 407
Michael Salacz United States 9 112 0.8× 101 0.8× 168 1.4× 53 0.6× 90 1.3× 20 469
Junyang Zhao China 7 128 1.0× 149 1.2× 45 0.4× 39 0.4× 77 1.1× 15 465
Jane Stevens United Kingdom 8 221 1.7× 55 0.4× 157 1.3× 46 0.5× 44 0.6× 12 620
F. M. Fink Austria 11 125 0.9× 68 0.5× 60 0.5× 53 0.6× 103 1.5× 21 439
Inés Gómez‐Seguí Spain 11 178 1.3× 56 0.4× 93 0.8× 95 1.1× 24 0.4× 60 603

Countries citing papers authored by Tom B. Davidson

Since Specialization
Citations

This map shows the geographic impact of Tom B. Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom B. Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom B. Davidson more than expected).

Fields of papers citing papers by Tom B. Davidson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom B. Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom B. Davidson. The network helps show where Tom B. Davidson may publish in the future.

Co-authorship network of co-authors of Tom B. Davidson

This figure shows the co-authorship network connecting the top 25 collaborators of Tom B. Davidson. A scholar is included among the top collaborators of Tom B. Davidson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom B. Davidson. Tom B. Davidson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davidson, Tom B., et al.. (2024). Immune checkpoint inhibitors and endocrinopathies in pediatric brain tumor patients. Journal of Pediatric Endocrinology and Metabolism. 38(1). 58–64.
2.
Margol, Ashley, Tom B. Davidson, Benita Tamrazi, et al.. (2024). Disease Evolution Monitored by Serial Cerebrospinal Fluid Liquid Biopsies in Two Cases of Recurrent Medulloblastoma. International Journal of Molecular Sciences. 25(9). 4882–4882. 3 indexed citations
3.
Margol, Ashley, et al.. (2023). OUTC-06. BEST PRACTICES FOR THE SUCCESSFUL ADMINISTRATION OF COMBINATION METRONOMIC ANTI-ANGIOGENIC AND INTRAVENTRICULAR THERAPY. Neuro-Oncology. 25(Supplement_1). i36–i36. 1 indexed citations
4.
Foster, Jessica, Marta M. Alonso, Elias Sayour, et al.. (2023). Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology. Neoplasia. 42. 100909–100909. 8 indexed citations
5.
Waanders, Angela J., Alex Brown, Nadine R. Caron, et al.. (2023). Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagement. Neoplasia. 37. 100879–100879. 6 indexed citations
6.
Margol, Ashley, Linda M. Szymanski, Benita Tamrazi, et al.. (2022). ETMR-16. Embryonal tumors with multi-layered rosettes: A case series in treatment for newly diagnosed children. Neuro-Oncology. 24(Supplement_1). i53–i53. 1 indexed citations
7.
Friedman, Gregory K., et al.. (2022). MEDB-86. A re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology. 24(Supplement_1). i126–i127.
8.
Cotter, Jennifer, et al.. (2020). Primary diffuse leptomeningeal glioneuronal tumors of the central nervous system: Report of three cases and review of literature. Pediatric Hematology and Oncology. 37(3). 248–258. 12 indexed citations
9.
Abdelbaki, Mohamed S, Tom B. Davidson, Jason Fangusaro, et al.. (2020). Pineoblastoma in children less than six years of age: The Head Start I, II, and III experience. Pediatric Blood & Cancer. 67(6). e28252–e28252. 10 indexed citations
10.
Prins, Robert M., Aaron Mochizuki, Joey Orpilla, et al.. (2018). ATIM-12. NEOADJUVANT ANTI-PD-1 IMMUNOTHERAPY PROMOTES INTRATUMORAL AND SYSTEMIC IMMUNE RESPONSES IN RECURRENT GLIOBLASTOMA: AN IVY CONSORTIUM TRIAL. Neuro-Oncology. 20(suppl_6). vi3–vi3. 1 indexed citations
11.
Orpilla, Joey, Aaron Mochizuki, Neha Akkad, et al.. (2018). ATIM-25. NEOADJUVANT PD-1 ANTIBODY BLOCKADE IS ASSOCIATED WITH FOCAL UPREGULATION OF PD-L1 AND CD8 T CELL INFILTRATE IN RECURRENT GLIOBLASTOMA. Neuro-Oncology. 20(suppl_6). vi6–vi6. 2 indexed citations
12.
Wong, Kenneth, Sean All, Arthur J. Olch, et al.. (2017). Radiotherapy after high‐dose chemotherapy with autologous hematopoietic cell rescue: Quality assessment of Head Start III. Pediatric Blood & Cancer. 64(10). 2 indexed citations
13.
Sedighim, Shaina, Tina Wang, Joseph Antonios, et al.. (2016). TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination. Cancer Immunology Research. 4(5). 412–418. 53 indexed citations
14.
Hall, Clinton, Beate Ritz, Myles Cockburn, Tom B. Davidson, & Julia E. Heck. (2016). Risk of malignant childhood germ cell tumors in relation to demographic, gestational, and perinatal characteristics. Cancer Epidemiology. 46. 42–49. 15 indexed citations
15.
Weil, Alexander G., Anthony Wang, Harrison J. Westwick, et al.. (2016). Survival in pediatric medulloblastoma: a population-based observational study to improve prognostication. Journal of Neuro-Oncology. 132(1). 99–107. 29 indexed citations
16.
Heck, Julia E., Andrew S. Park, Zuelma A. Contreras, et al.. (2016). Risk of Childhood Cancer by Maternal Birthplace. JAMA Pediatrics. 170(6). 585–585. 21 indexed citations
17.
Erdreich‐Epstein, Anat, Nathan Robison, Xiuhai Ren, et al.. (2013). PID1 ( NYGGF4 ), a New Growth-Inhibitory Gene in Embryonal Brain Tumors and Gliomas. Clinical Cancer Research. 20(4). 827–836. 26 indexed citations
18.
Venkatramani, Rajkumar, Marcio H. Malogolowkin, Tom B. Davidson, et al.. (2013). A Phase I Study of Vincristine, Irinotecan, Temozolomide and Bevacizumab (Vitb) in Pediatric Patients with Relapsed Solid Tumors. PLoS ONE. 8(7). e68416–e68416. 36 indexed citations
19.
Lasky, Joseph L., Eduard H. Panosyan, Ashley Plant, et al.. (2013). Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas.. PubMed. 33(5). 2047–56. 56 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arthur Wingerter Breakdown of academic impact, for papers by Gabriel N. Mannis Breakdown of academic impact, for papers by Hien K. Duong Breakdown of academic impact, for papers by Claudia Pasqualini Breakdown of academic impact, for papers by J. P. Lamagnere Breakdown of academic impact, for papers by Michael Salacz Breakdown of academic impact, for papers by Junyang Zhao Breakdown of academic impact, for papers by Jane Stevens Breakdown of academic impact, for papers by F. M. Fink Breakdown of academic impact, for papers by Inés Gómez‐Seguí
Rankless by CCL
2026